Javascript must be enabled to continue!
Parkinson Disease
View through CrossRef
Levodopa is the most efficacious medication to reduce motor impairment in Parkinson disease (PD). The effect of levodopa can wear off after time, which is treated by increasing the dose or shortening the inter-dose interval. Dyskinesias can be treated by a change in levodopa dosing or route of administration, such as by constant administration of levodopa as a gel through a jejunostomy tube or a change to dopamine agonists or amantadine. Non-motor signs including depression can be treated with several antidepressants. Surgical treatments including pallidotomy, thalamotomy, and deep brain stimulation (DBS) have emerged as effective therapies in selected patients with PD refractory to drug treatment.
Title: Parkinson Disease
Description:
Levodopa is the most efficacious medication to reduce motor impairment in Parkinson disease (PD).
The effect of levodopa can wear off after time, which is treated by increasing the dose or shortening the inter-dose interval.
Dyskinesias can be treated by a change in levodopa dosing or route of administration, such as by constant administration of levodopa as a gel through a jejunostomy tube or a change to dopamine agonists or amantadine.
Non-motor signs including depression can be treated with several antidepressants.
Surgical treatments including pallidotomy, thalamotomy, and deep brain stimulation (DBS) have emerged as effective therapies in selected patients with PD refractory to drug treatment.
Related Results
Descobrindo a doença de Parkinson: 100 perguntas e respostas
Descobrindo a doença de Parkinson: 100 perguntas e respostas
Nesta obra, a Dra. Mariana Moscovich, que possui mais de 10 anos de experiência tratando pacientes com a doença de Parkinson, explana sobre os principais assuntos abordados no dia ...
Parkinson Disease
Parkinson Disease
Parkinson disease is a neurodegenerative disorder characterized clinically by tremor, rigidity, bradykinesia, and postural instability and pathologically by loss of nigrostriatal n...
Gaucher Disease
Gaucher Disease
Gaucher disease is frequently diagnosed in adulthood and may manifest at any age. Chronic neuronopathic forms are rarely seen but may come to the attention of the adult physician. ...
“I See Them Sitting on My Bed, Doctor”
“I See Them Sitting on My Bed, Doctor”
Many movement disorders specialists would consider dementia with Lewy bodies to be on one end of a spectrum of presentations associated with Lewy body pathology. Parkinson’s diseas...
Diagnosis and Therapy for Lewy Body Dementia
Diagnosis and Therapy for Lewy Body Dementia
Almost undistinguished some 30 years ago, dementia with Lewy bodies is now shown to be the second most common neurodegenerative cause of dementia in the elderly. A host of neuroinf...
Neurological Disorders of Attention
Neurological Disorders of Attention
Attention deficits are a frequent and particularly disabling consequence of many neurological disorders, from patients with focal brain lesions through to individuals with traumati...
Rheumatoid arthritis—management
Rheumatoid arthritis—management
Influential guidelines on rheumatoid arthritis (RA) management agree on most key recommendations. Early diagnosis of persistent synovitis, and identification of poor prognostic mar...
A History of Multiple Sclerosis
A History of Multiple Sclerosis
While we now recognize that MS is a common neurological disease, as late as the early twentieth century it was considered a relatively rare condition in Europe and the United State...

